本页面由Tiger Trade Technology Pte. Ltd.提供服务

Abeona Therapeutics Inc

4.82
+0.24005.24%
盘后4.880.0645+1.34%16:27 EDT
成交量:76.65万
成交额:366.21万
市值:2.75亿
市盈率:4.77
高:4.84
开:4.50
低:4.50
收:4.58
52周最高:7.54
52周最低:3.93
股本:5,704.90万
流通股本:4,260.33万
量比:0.73
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):1.01
每股收益(LYR):1.01
净资产收益率:70.05%
总资产收益率:-34.04%
市净率:1.73
市盈率(LYR):4.77

数据加载中...

2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/11

重要事件披露

8-K - Current report
2023/04/10

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

重要事件披露

8-K - Current report
2023/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals